TB

The multimedia videos are targeted to community health providers, including those working at Federally Qualified Health Centers. The series contains three videos, each of which is 6 -15 minutes long, and seamlessly incorporate images, voice and text. The videos cover screening, diagnosis and treatment of LTBI. The videos can be viewed from a computer, laptop, smartphone or tablet, where you are - at home, work or on the go. Resources and transcripts are also available.

These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals. You can share individual stories on social media using the social media graphics included on several of the survivor story pages.

This issue focuses on the story of Raquel Orduño, whose on-going TB advocacy began with a group of people who came together to document and portray their experiences with TB along the United States (U.S.)-Mexico border. It also includes information on advocacy, social support and supportive language.

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

Dr. Kenneth Castro explains why it is important for people living with HIV to be tested for TB.

This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.

Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.

This report summarizes the accomplishments and activities of the Stop TB Partnership in 2011.

This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.